In severe asthma with an eosinophilic phenotype, depemokimab improved exacerbations, but not quality of life, at 52 wk

被引：0
|
作者：
McDonald, Christine F. [1 ,2 ]
机构：
[1] Austin Hosp, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
来源：
ANNALS OF INTERNAL MEDICINE | 2025年 / 178卷 / 01期
关键词：
D O I：
10.7326/ANNALS-24-03437-JC
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical Impact Ratings GIM/FP/GP: Allerg & Immunol: Pulmonology:
引用
收藏
页码：JC8 / JC8
页数：1
相关论文
共 50 条
  • [31] In severe, uncontrolled asthma, tezepelumab reduced exacerbations and improved asthma control at 1 y
    Taleb, Ali A.
    Badgett, Robert G.
    ANNALS OF INTERNAL MEDICINE, 2021, 174 (10) : JC115 - JC115
  • [32] Effectiveness of mepolizumab therapy on symptoms, asthma exacerbations, steroid dependence, and small airways in patients with severe eosinophilic asthma
    Yilmaz, Insu
    Nazik Bahcecioglu, Sakine
    Turk, Murat
    Tutar, Nuri
    Pacaci Cetin, Gulden
    Arslan, Bahar
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021, 51 (04) : 1953 - 1959
  • [33] Real-life treatment of severe eosinophilic asthma with mepolizumab
    Pelaia, Corrado
    Busceti, Maria Teresa
    Solinas, Sabina
    Terracciano, Rosa
    Pelaia, Girolamo
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [34] Mepolizumab in real-life treatment of severe eosinophilic asthma
    Volakova, Eva
    Zatloukal, Jaromir
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [35] Sleep quality and asthma control and quality of life in non-severe and severe asthma
    Luyster, Faith S.
    Teodorescu, Mihaela
    Bleecker, Eugene
    Busse, William
    Calhoun, William
    Castro, Mario
    Chung, Kian Fan
    Erzurum, Serpil
    Israel, Elliot
    Strollo, Patrick J.
    Wenzel, Sally E.
    SLEEP AND BREATHING, 2012, 16 (04) : 1129 - 1137
  • [36] Sleep quality and asthma control and quality of life in non-severe and severe asthma
    Faith S. Luyster
    Mihaela Teodorescu
    Eugene Bleecker
    William Busse
    William Calhoun
    Mario Castro
    Kian Fan Chung
    Serpil Erzurum
    Elliot Israel
    Patrick J. Strollo
    Sally E. Wenzel
    Sleep and Breathing, 2012, 16 : 1129 - 1137
  • [37] REAL-LIFE TREATMENT OF SEVERE EOSINOPHILIC ASTHMA WITH BENRALIZUMAB
    Pelaia, C.
    Busceti, M. T.
    Vatrella, A.
    Rago, G. F.
    Crimi, C.
    Pelaia, G.
    CHEST, 2020, 157 (06) : 6A - 6A
  • [38] Mepolizumab for severe eosinophilic asthma - real-life data
    Braganca, M.
    Amaral, L.
    Placido, J. L.
    ALLERGY, 2021, 76 : 171 - 172
  • [39] Blood Eosinophil Phenotype During Treatment With Mepolizumab in Patients With Severe Eosinophilic Asthma
    Sakai, C.
    Matsuyama, M.
    Nakajima, M.
    Matsumura, S.
    Nonaka, M.
    Arai, N.
    Kuramoto, K.
    Yoshida, K.
    Morishima, Y.
    Muratani, M.
    Hizawa, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [40] Exhaled nitric oxide identifies the persistent eosinophilic phenotype in severe refractory asthma
    Silkoff, PE
    Lent, AM
    Busacker, AA
    Katial, RK
    Balzar, S
    Strand, M
    Wenzel, SE
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2005, 116 (06) : 1249 - 1255
12345